Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism

Archives of Gynecology and Obstetrics

Volumn 274, Issue 4, 2006, Pages 227-232

  Hassa, H ^a   Tanir, H M ^a   Yildiz, Z ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Anovulation; Hirsutism; Hyperandrogenism; Oligomenorrhea; Polycystic ovarian syndrome

Indexed keywords

ANDROSTENEDIONE; C PEPTIDE; ESTRADIOL; FOLLITROPIN; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE; ADULT; ALOPECIA; ANOVULATION; ARTICLE; BODY MASS; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FERRIMAN GALLWEY SCORE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HOSPITAL ADMISSION; HUMAN; HYPERANDROGENISM; LABORATORY TEST; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MORPHOLOGY; OILY SKIN; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PHENOTYPE; RETROSPECTIVE STUDY; SCORING SYSTEM; SYMPTOMATOLOGY; TURKEY (REPUBLIC); WAIST HIP RATIO;

ADULT; ANOVULATION; DEMOGRAPHY; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; ORGAN SIZE; OVARY; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES;

EID: 33745505167     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-006-0173-8     Document Type: Article

References (22)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southern eastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
2. Sheehan MT (2004) Polycystic ovarian syndrome: diagnosis and management. Clin Med Res 2(1):13-27
3. Tarkun I, Arslan BC, Canturk Z, Turemen E, Sahin T, Duman C (2005) Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. Obstet Gynecol Surv 60(3):180-181
4. Ehrmann DA (2005) Polycystic ovarian syndrome. N Engl J Med 352(12):1223-1236
5. Zawadski JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F (eds) Polycystic ovary syndrome. Blackwell Scientific, Boston, pp. 377-384
6. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
7. Azziz R (2004) PCOS: diagnostic challenge. Reprod Biomed Online 8(6):644-648
8. Azziz R (2005) Diagnostic criteria for polycystic ovarian syndrome: a reappraisal. Fertil Steril 83(5):1343-1346
9. Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1444
10. Diamanti-Kandarakis, Koulie CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al (1999) A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: a hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
11. Kamel N, Tunyukuk V, Emral R, Corapcioglu D, Bastemir M, Gullu S (2005) Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 113(2):115-121
12. Yildiz BO, Gedik O (2004) Assessment of glucose intolerance and insulin sensitivity in polycystic ovarian syndrome. Reprod Biomed Online 9(1):7-14
13. Adams JM, Taylor AE, Crowley WF Jr, Hall JE (2005) Polycystic ovarian morphology with regular ovulatory cycles: insight into the pathophysiology of polycystic ovarian syndrome. Obstet Gynecol Surv 60(4):239-240
14. Hassa H, Tanir HM, Yildirim A, Senses T, Eskalen M, Mutlu FS (2005) The hirsutism scoring system should be population specific. Fertil Steril 84(3):778-780
15. Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A (2005) Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 90(5):2571-2579
16. Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90(5):2545-2549
17. Plymate SR, Farris BL, Bassett ML, Matej L (1981) Obesity and its role in polycystic ovarian syndrome. J Clin Endocrinol Metab 52:1246-1248
18. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with polycystic ovarian syndrome. J Clin Endocrinol Metab 72:83-89
19. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA (1999) Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol 69(1-6):481-485
20. Avvakumo G, Strel'chyonok O (1990) Pregnancy-associated variant of human CBG: molecular and biochemical properties, blood levels, and possible clinical implications. J Steroid Biochem 36(Suppl.):103-117
21. Kahn SM, Hryb DJ, Nakhla AM, Romas NA, Rosner W (2002) Sex hormone-binding globulin is synthesized in target cells. J Endocrinol 175(1):113-120
22. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ (2005) Polycystic ovarian syndrome: marked differences between endocrinologists and gynecologists in diagnosis and management. Clin Endocrinol 62(3):289-295